Lehman Financial Resources, Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 144 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lehman Financial Resources, Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$1,000
-50.0%
2000.0%0.00%0.0%
Q2 2015$2,000
-33.3%
2000.0%0.00%0.0%
Q1 2015$3,0000.0%2000.0%0.00%0.0%
Q4 2014$3,000
+50.0%
2000.0%0.00%0.0%
Q3 2014$2,000
-33.3%
2000.0%0.00%0.0%
Q2 2014$3,000
-25.0%
2000.0%0.00%
-50.0%
Q1 2014$4,000
+33.3%
2000.0%0.00%0.0%
Q4 2013$3,000
+50.0%
2000.0%0.00%
+100.0%
Q3 2013$2,0000.0%2000.0%0.00%0.0%
Q2 2013$2,0000.0%2000.0%0.00%0.0%
Q1 2013$2,000
+100.0%
2000.0%0.00%0.0%
Q4 2012$1,0002000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders